Cowen And Company, LLC 10x Genomics, Inc. Transaction History
Cowen And Company, LLC
- $3.88 Billion
- Q3 2024
A detailed history of Cowen And Company, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 17,200 shares of TXG stock, worth $258,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,200Holding current value
$258,000% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TXG
# of Institutions
289Shares Held
95.8MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$165 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$161 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$97.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$95.9 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$95.6 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.43B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...